Editorial Policy

1. Program facts

LevelsRx-specific pricing, medication options, advertised service features and eligibility statements are sourced from LevelsRx and date-stamped when they can change.

2. Medical and regulatory facts

We prefer primary public-health sources such as FDA labeling, FDA safety notices and official government health coverage pages. We do not invent efficacy claims for compounded products or imply that compounded drugs are FDA-approved equivalents.

3. Semantic content method

Pages are organized around entities, attributes, values and contextual relationships. For example, the entity LevelsRx is described through attributes such as service type, clinician access, medication options, price, insurance support and fulfillment. The entity semaglutide is described through drug class, approved products, compounded status and safety context.

We use direct subject–predicate–object sentences when precision matters: “LevelsRx provides telehealth access.” “Licensed clinicians evaluate patients.” “Pharmacies dispense prescriptions.” “Insurers determine coverage.” This structure improves readability and factual extraction without keyword stuffing.

4. Internal linking

Internal links are used when two pages share a meaningful semantic bridge. The cost page links to insurance because coverage can alter out-of-pocket cost. The semaglutide page links to the comparison page because semaglutide and tirzepatide are related medication entities.

5. Affiliate independence

Affiliate compensation can create a material connection. We disclose that relationship clearly and conspicuously. We do not publish fabricated testimonials, fake star ratings or invented medical credentials.

6. Corrections

Program terms, prices and regulation can change. Material factual updates should include a new modified date. Readers can report a correction through the contact page.